维普中文期刊产品整合服务
56篇 您的检索式:作者名="Baraf"
    题名 作者 年代 出处 被引量
12011 Recommen-dations for the diagnosis and management of gout and hyperurice-mia显示文摘Hamburger M Baraf HS Adamson TC 3rd 2011Postgrad Med2011,123,61:1
22011 Recommendations for the diagnosis and management of gout and hyperuricemia显示文摘Hamburger M Baraf H S Adamson T C 0,,6:1
3Reduction ofplasma urate levels following treatment with multiple doses of pe-gloticase(polyethylene glycol-conjugated uricase)in patientswith treatment-failure gout:results of a phase II randomized study显示文摘SUNDY JS BECKER MA BARAF HS 2008Arthritis Rheum2008,58,9:1
4Efficacy andsafety of intravenous(IV)pegloticase(PGL)in subjects withtreatment failure gout(TFG):Phase 3 results from GOUT1 andGOUT2显示文摘SUNDY JS BARAF HS BECKER MA 2008Arthritis Rheum2008,58,9:1
5Chro-nic use of pegloticase:safety and efficacy update显示文摘SUNDY JS BARAF HS GUTIERREZ-URENA SR 2009ArthritisRheum2009,60,10:1
6Resolution of gouty tophi after twelve weeks of pegloticase treatment显示文摘Baraf H S Matsumoto A K Maroli A N 2008Ar- thritis Rheum2008,58,11:1
7Tophus response to pegloticase (PGL) therapy: pooled results from GOUTI and GOU'I2, PGL phase 3 randomized, double blind, placebocontrolled trims 显示文摘BARAF H S BECKER M A EDWARDS N L 2008Arthritis Rheum2008,58,9:1
82011 Recommendations for the diagnosis and management of gout and hyperuricemia 显示文摘Hamburger M Baraf HS Adamson TC 3rd 2011Postgrad Med2011,123,61:1
92011 recommendations for the diagnosis and management of gout and hyperurieemia 显示文摘Hamburger M Baraf HS Adamson TC 2011Phys Sportsmed2011,39,:1
10Efficacy and tolerability ofpegloticase for the treatment of chronic gout in patients refractory toconventional treatments显示文摘Sundy JS Baraf HSB Yood RA 2011JAMA2011,306,5:1
11Safety and efficacy of topical diclofenac sodium gel for knee osteoarthritis in elderly and younger patients: pooled data from three randomized, double-blind, parallel-group, placebo-controlled, multicentre trials 显示文摘Baraf HS Gloth FM Barthel HR 2011Drugs Aging2011,28,1:1
12Resolution of tophi with intravenous Peg-uriease in refractory gout显示文摘Baraf HSB Kim S Matsumoto AK 2005Arthritis Rheum2005,52,:1
13Efficacy and tolerability of pe- gloticase for the treatment of chronic gout in patients refractory to conventional treatment : two randomized controlled trims 显示文摘Sundy JS Baraf HS Yood RA 2011JAMA2011,306,:1
14Resolution of to-phi with intravenous PEG uricase in refractory gout显示文摘Baraf H Kim S Matsumoto A K 2005Arthritis Rheum2005,50,9:1
15Isolated epidermolytic acanthoma:a solitary tumor showing granular Degeneration显示文摘Shapior L Baraf CS 1970Arch Dermatol1970,101,:1
162011 Recommendation for the diagnosis and management of gout and hyperuricemia显示文摘Hamburger M Baraf HS Adamson TC 2011PhysSportsmed2011,39,4:1
17Resolution of tophi with intravenous PEG-uricase in refractory gout显示文摘Baraf H Kim S AK M 2005Arthritis Rheum2005,50,9:1
18Recommen-dations for the diagnosis and management of gout and hyperuricemia显示文摘Hamburger M Baraf HS Adamson TC 2011Postgrad Med2011,123,61:1
19Reductionof plasma urate levels following treatment with multiple doses of pegloticase (polycthylene glycol-conjugateduricase) in patients with treatment-failure gout:Resultsof a phase Ⅱ randomized study显示文摘Sundy JS Becker MA Baraf HS 2008Arthritis Rheum2008,58,9:1
20Efficacy and safety of intravenous (iv) pegloticase (PGL) in subjects with treatment failure gout (TFG):Results from GOUT1 and GOUT2显示文摘Sundy JS Baraf HS Becker MA 2008Arthritis Rhcum2008,58,9:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费